Why Spain for a Swedish biopharmaceutical company looking to expand?

The biopharmaceutical sector is one of Spanish strategic sectors due to its high added value for the Spanish business ecosystem, being one of the top ten sectors in the country in terms of stock in millions of euros of foreign direct investment. In addition, more than 60% of the pharmaceutical companies established in Spain are foreign-owned and have research, development and production centres of recognised prestige.

By joining this webinar, you will be able to learn about the strengths of Spain as a business location and investment destination in the biopharmaceutical sector, highlighting our country’s leadership as one of the main innovation hubs for new developments in healthcare.

With an extensive network of 800 hospitals, both public and private, backed by leading-edge research centers, the Spanish healthcare system is ideal for translational medicine, the development of new drugs and advanced therapies. In addition, Spain is 12^th world scientific power and 3^rd by scientific production in the EU as well as a world leader in clinical testing.